Physician profile
Thomas C Nicholson
NPI 1366428096
$5,305.12
in general payments reported to CMS, 2019-2025
40 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $246 · 2021: $630 · 2022: $840 · 2023: $1,051 · 2024: $1,277 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,955 · Education: $22.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,955.47 |
| Education | $22.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,122.03 | 2019-2024 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $920.99 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Rezum Generator |
| Janssen Biotech, INC. | $532.65 | 2019-2025 | Erleada |
| Pfizer INC. | $388.94 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $323.01 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $247.86 | 2019-2025 | |
| Coloplast Corp | $236.32 | 2021-2025 | Titan, Saffron |
| Glaxosmithkline, LLC. | $214.07 | 2024-2025 | Nucala |
| Endo Pharmaceuticals INC. | $112.87 | 2019-2023 | Xiaflex, Aveed |
| Axonics, INC. | $108.61 | 2021-2024 | Axonics |
| Procept Biorobotics Corporation | $104.34 | 2022-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $101.18 | 2024-2025 | Provenge |
| Urogen Pharma, INC. | $80.26 | 2020-2024 | |
| Urovant Sciences INC | $73.58 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.14 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.